Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707104200 on April 7, 2008

J. Biol. Chem., Vol. 283, Issue 23, 16124-16134, June 6, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/23/16124    most recent
M707104200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, H. R.
Right arrow Articles by Connor, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, H. R.
Right arrow Articles by Connor, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of Recombinant Human T-type Calcium Channels by {Delta}9-Tetrahydrocannabinol and Cannabidiol*

Hamish Redmond Ross1, Ian Napier2, and Mark Connor3

From the Pain Management Research Institute, Kolling Institute, University of Sydney at Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia

{Delta}9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most prevalent biologically active constituents of Cannabis sativa. THC is the prototypic cannabinoid CB1 receptor agonist and is psychoactive and analgesic. CBD is also analgesic, but it is not a CB1 receptor agonist. Low voltage-activated T-type calcium channels, encoded by the CaV3 gene family, regulate the excitability of many cells, including neurons involved in nociceptive processing. We examined the effects of THC and CBD on human CaV3 channels stably expressed in human embryonic kidney 293 cells and T-type channels in mouse sensory neurons using whole-cell, patch clamp recordings. At moderately hyperpolarized potentials, THC and CBD inhibited peak CaV3.1 and CaV3.2 currents with IC50 values of ~1 µM but were less potent on CaV3.3 channels. THC and CBD inhibited sensory neuron T-type channels by about 45% at 1 µM. However, in recordings made from a holding potential of -70 mV, 100 nM THC or CBD inhibited more than 50% of the peak CaV3.1 current. THC and CBD produced a significant hyperpolarizing shift in the steady state inactivation potentials for each of the CaV3 channels, which accounts for inhibition of channel currents. Additionally, THC caused a modest hyperpolarizing shift in the activation of CaV3.1 and CaV3.2. THC but not CBD slowed CaV3.1 and CaV3.2 deactivation and inactivation kinetics. Thus, THC and CBD inhibit CaV3 channels at pharmacologically relevant concentrations. However, THC, but not CBD, may also increase the amount of calcium entry following T-type channel activation by stabilizing open states of the channel.


Received for publication, August 24, 2007 , and in revised form, March 27, 2008.

* This work was supported in part by National Health & Medical Research Council of Australia Project 402564 (to M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by a University of Sydney postgraduate award and a Kolling Institute Award.

2 Supported by an Australian Postgraduate Award and a Ramsay Healthcare Award.

3 To whom correspondence should be addressed: Pain Management Research Inst., Level 5, Main Block, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia. Tel.: 61-2-9926-518; Fax: 61-2-9906-4079; E-mail: markc{at}med.usyd.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement